In pancreatic cancer, YBX1 interacts with the epigenetic regulator CBX3 to promote cancer progression by inhibiting the expression of SMAD specific E3 ubiquitin protein ligase 2 (SMURF2) and activating TGF-β signaling (16) (Figure 1). Here, YBX1 is linked to pancreatic neoplasm.